Igarashi Ryoko, Togano Tetsuya, Sakaue Yuta, Yoshino Takaiko, Ueda Jun, Fukuchi Takeo
Department of Ophthalmology and Visual Science, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
J Ophthalmol. 2014;2014:720385. doi: 10.1155/2014/720385. Epub 2014 Nov 19.
Purpose. To evaluate the effect on intraocular pressure (IOP) of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in Japanese patients with normal-tension glaucoma (NTG). Methods. 27 NTG patients (54 eyes) were compared IOP, superficial punctuate keratitis (SPK) scores, and conjunctival injection scores in eyes treated with prostaglandin (PG) or PG analog/beta-blocker (PG/b) fixed-combination 6 months after the change in therapy. Results. The mean baseline intraocular pressure was 17.4 ± 1.59 mmHg in eyes receiving PG therapy only and 17.4 ± 1.69 mmHg in eyes switched to PG/b. Switching to fixed combination therapy from PG monotherapy, the mean IOP was 13.1 ± 1.79 mmHg (P < 0.001) (-24.71% reduction from baseline) at 6 months. The mean conjunctival injection score was 0.69 for eyes on PG monotherapy and 0.56 for eyes on fixed combination therapy (P = 0.028). The mean SPK scores were 0.46 and 0.53. This difference was not statistically significant (P = 0.463). Conclusions. Switching from PG monotherapy to PG/b fixed combination therapy for NTG resulted in a greater intraocular pressure reduction than PG alone without increasing the number of instillations.
目的。评估在日本正常眼压性青光眼(NTG)患者中,从拉坦前列素和曲伏前列素单药治疗转换为噻吗洛尔固定复方制剂对眼压(IOP)的影响。方法。比较27例NTG患者(54只眼)在治疗改变6个月后,使用前列腺素(PG)或PG类似物/β受体阻滞剂(PG/b)固定复方制剂治疗的眼的眼压、浅层点状角膜炎(SPK)评分和结膜充血评分。结果。仅接受PG治疗的眼的平均基线眼压为17.4±1.59 mmHg,转换为PG/b的眼为17.4±1.69 mmHg。从PG单药治疗转换为固定复方制剂治疗后,6个月时平均眼压为13.1±1.79 mmHg(P<0.001)(较基线降低24.71%)。PG单药治疗的眼的平均结膜充血评分为0.69,固定复方制剂治疗的眼为0.56(P = 0.028)。平均SPK评分为0.46和0.53。这种差异无统计学意义(P = 0.463)。结论。NTG患者从PG单药治疗转换为PG/b固定复方制剂治疗可使眼压降低幅度大于单用PG,且不增加滴眼次数。